Skip to main content
. 2015 Sep 23;2015(32):6965–6982. doi: 10.1002/ejoc.201500852

Figure 1.

Figure 1

An ω-transaminase variant produced by directed evolution enabled the stereoselective amination of a bulky-bulky ketone for the production of sitagliptin (2), a drug used in the treatment of type II diabetes.